Steep Hill Labs, Inc.

Berkeley, CA 94710, US
Biotechnology
steephill.com

Steep Hill is the premiere cannabis analytical lab in the country with 3 company-owned labs (Berkeley, Seattle and Albuquerque) and two licensed labs (Denver and Las Vegas).

Steep Hill is also an innovative R&D lab that has two proprietary products

Steep Hill Labs opened the first commercial cannabis lab in the United States in 2007. Now, with labs in 5 states, 5 Ph.D Scientists on staff and a recently-launched a state-of-the art Genetics Lab , Steep Hill is the country's leading cannabis analytical lab. In addition to its core testing business, Steep Hill is also innovative product development Lab that has already developed and commercialized two proprietary products: the QuantaCann and the GenKit.

The QuantaCann is an on-site potency and moisture machine that provides important analytical information with respect to marijuana samples in 60 seconds. The QuantaCann was featured on CSI Vegas as the scientific equipment used to solve a murder in a marijuana dispensary. The QuantaCann 2 is set for release by April 1, 2016. It is a less expensive yet even more accurate model, rivaling the accuracy of the most robust laboratory equipment. The scientists at Steep Hill are busy developing the next generation of QuantaCann which will have an upgraded user interface and the ability to test the potency of concentrates, the fastest growing segment of the cannabis retail market.

The GenKit is the first product offering to come out of our Genetics Lab and was introduced to the market as of March 1, 2015. The GenKit contains 8 test packages which allow growers to clip a tiny portion of a seedling leaf and then send that package to the Lab. Once received, our geneticists are able to identify which plants are male plants. That information is then communicated to the customer through a convenient tracking system and the grower is then able to use this information to cull the male plants much sooner than could be done without the assistance of a genetics lab. This results in the saving of time, energy and resources and increased crop yield.

Steep Hill is investing in its expansion, infrastructure and human capital to maintain its leadership position and to provide the best cannabis science.

General Information

 
 
 
 
 

Social Links

Company Industry

Select Industry:

Company Description

0 / 250
 
0 / 2000
 

Summary

Prior Year Revenue Current Year Revenue Next Year Revenue
Company Age Employees Sub-Industry
10 years, 9 months 30 Other Biotechnology
Company Type Stock Exchange Stock Symbol
Privately-Held - -

Company Financials

Viewable by EquityNet investors only

Company Age & Size

Stock Exchange

Is this company privately-held or publicly-traded?

Products / Services

0 / 1000
Cannabis Testing Services; Genetics Lab; QuantaCann; GenKits

Steep Hill Labs is a commercial cannabis analytical laboratory that tests marijuana and marijuana-derived products to ensure compliance with public safety standards and to provide consumers with information with respect to potency, cannabinoid profile and moisture. Steep Hill has labs in 5 states and has plans to open up 2 additional labs in 2016. Steep Hill recently launched a state-of-the-art Genetics Lab and, in addition to its core testing business, Steep Hill is an innovative product development Lab that has already developed and commercialized two proprietary products: the QuantaCann and the GenKit.

The QuantaCann is an on-site instant potency and moisture diagnostic machine. The QuantaCann provides potency, cannabinoid profile and moisture information and was recently approved by the State of New Mexico to conduct state-mandated tests.

The GenKit, provides growers with genetic information regarding their seedlings that assist in cultivation decisions.

Management

0 / 1000
General Counsel/Legal Officer
Mitch Kulick

As Steep Hill's General Counsel, Mr. Kulick manages the company’s contractual relationships with customers, suppliers, and licensees and serves as a member of Steep Hill’s executive management team. He is the company liaison to Steep Hill's investors and government regulators. In addition, Mr. Kulick works with outside counsel to protect Steep Hill's intellectual property and business interests.

Prior to joining Steep Hill, Mr. Kulick served for 8 years as the General Counsel and Chief Compliance Officer for Iroquois Capital, a leading hedge fund and private equity fund in New York City. Prior to joining Iroquois, Mr. Kulick worked for the Securities & Exchange Commission where he was a staff attorney in the Enforcement Division of the New York Regional Office. Mr. Kulick's legal career began in the New York office of Greenberg Traurig. While there, he worked on complex corporate reorganizations, labor disputes and securities litigation matters.

Funding

65%

Funding Goal$5,000,000

Funding Raised So Far$3,250,000

Funding Commitments$0

Funding Remaining$1,750,000

Funding TypeConvertible Debt

Pre-Money Valuation

Investor Ownership

Interest / Dividend

Previous Funding

General Funding

Showing your General Funding information publicly may constitute general solicitation. General solicitation is a new commonly-used way for companies to raise funding. To learn about general solicitation, consult your legal counsel. If you uncheck this box, your General Funding information will be viewable to only EquityNet investors.

Private Funding

Viewable by EquityNet investors only

Video

Images

Documents

Complete a Business Plan in EquityNet

Your EquityNet business plan is only viewable to capital providers and business supporters that you choose to share with in the “Crowdfund” or “Messages” tab. Investors prefer an EquityNet business plan. Entering a plan is highly educational and improves your appeal to investors.

Upload Documents

Document file names will be viewable by EquityNet investors and business supporters only. Actual documents are only viewable to capital providers and business supporters that you choose to share with in the “Crowdfund” or “Messages” tab.

Share Your Public Profile Page

Users who follow all these tips increase their fundraising odds substantially.

  • Email your public page to all your LinkedIn contacts.
    • Post your page to your LinkedIn profile page.
  • Email your public page to all your Facebook contacts.
    • Post your page to your Facebook profile page.
  • Email your public page to all your Twitter contacts.
    • Post your page to your Twitter profile page.
  • Put your public page up on your website.
    • Don't have a website yet? Use this page as your site!
  • Share your page link anywhere there's a listing for your company.
    • Press Releases, Crunchbase, Wikipedia, Blogs, etc...
  • Email your public page to all your email contacts.
    • Use Outlook, Gmail, Yahoo Mail, Hotmail, etc...

Your Public Profile Page:

Would you like to share your public profile page with your email contacts?